Innventure

What they do

Innventure operates a unique "DownSelect" model where it systematically identifies, funds, and commercializes proprietary technologies from multinational corporations (MNCs) like Procter & Gamble and Dow. Rather than acting as a passive investor, Innventure serves as a co-founder and operator, taking majority ownership and management control of the new entities. They focus on "orphan" technologies-innovations that are fully developed but sit on the shelf because they don't fit the MNC's core business. The firm went public via a SPAC merger and currently trades on NASDAQ, mitigating early-stage technology risk by starting with proven IP and pre-validated market demand.

What they look for

Innventure’s thesis is built on "Mastering the Valley of Death"-the gap between corporate R&D innovation and commercial viability. They believe that MNCs hold billions of dollars in "stranded" IP that can be turned into billion-dollar businesses if managed by an agile, entrepreneurial team rather than a slow-moving corporate division. Their proprietary rigorous analysis process called DownSelect, using the MATCH scoring system, ensures technologies have massive market potential, proprietary advantage, quick commercialization timeline, manageable capital requirements, and potential for $1B+ Enterprise Value.

Stage

Ideation, Pre-seed, Series B+

Sectors

Deeptech, Climate, AI, SaaS

Based

Orlando, US